This year’s conference, entitled “Tomorrow’s Patient”, will take place the evenings of Tuesday and Wednesday, March 12th and 13th, 2019 at The Welcome Collection in London. To learn more about the event and reserve your space, please proceed to the “Conference agenda” and “Tickets” pages of this site.

Day 1

During the first evening of the conference, we will be exploring the impact of technology on the patient experience of consuming healthcare and interacting with healthcare providers. The evening will contain two main themes:

• Patient empowerment – Developments over the last 5-10 years have facilitated a retreat of healthcare provision from the hospital or doctor’s surgery, further in to the community and patients’ own homes. We will be looking at technologies that are enabling patients to be more involved and take charge of their own health and wellbeing, as well as those that make it easier to access specialist help when it is required. For Tomorrow’s Patient, ownership and convenience will be everything.
• E-Health in the mainstream – despite these advances, e-health remains largely in the confines of the private sector in the UK, with as yet limited integration into mainstream NHS care. Barriers to adoption include uncertainties around data protection and ownership, funding, clinician buy-in and fragmentation across providers. Our panel of speakers will elaborate and dive into each of these issues, as we develop a discussion around how new technologies can best be integrated into the NHS.

Day 2

Technology is not only shaping the patient-facing facade of healthcare, but we are seeing transformative changes in the models being used to bring that care to patients. During our second evening, we will discover how new technologies are impacting medical diagnoses as well as disrupting the traditional R&D models used to develop new medications:

• To efficiency, and beyond – to provide for Tomorrow’s Patient, efficiency is the name of the game. Providers need to develop new models to be able to raise throughput, and provide high standard services to more and more patients. We will learn about the new technologies which are helping to speed up diagnostic process and improve their accuracy, from traditional tests such as blood tests and biopsies, to algorithms speeding up the triage and interpretation of imaging.
• Farewell to the scatter-gun – Yesteryear’s Big Pharma played a quantity game; developing multiple compounds in the hope that one works. Given the rising cost of drug development and falling willingness of payers to pay, this is no longer feasible. Come and hear from the big guys changing the way things are done, and from the smaller guys who are helping them make it happen.